MAP2K7 and metastatic malignant neoplasm in the lymph nodes: Higher levels of MAPK8 and MAP2K7 gene expression were observed in patients with lymph node metastases (number 1–3) compared to patients without lymph node involvement (p = 0.0382; p = 0.0079).